Ministry of Health, Tanzania
12
0
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
90.0%
+3.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Rudi Kundini, Pamoja Kundini: Phase I
Role: collaborator
Rudi Kundini, Pamoja Kundini
Role: collaborator
Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania
Role: collaborator
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
Role: collaborator
Climat Impact on Urinary Iodine Concentration
Role: collaborator
Supporting Attendance for Facility Delivery and Infant Health
Role: collaborator
Counseling on Injectable Contraception and HIV Risk in Tanzania
Role: collaborator
Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in Care
Role: collaborator
HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings
Role: collaborator
A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria Tests
Role: collaborator
The Community Effectiveness of IPTi in Southern Tanzania
Role: collaborator
Efficacy Albendazole and Levamisole Against STH on Unguja
Role: collaborator
All 12 trials loaded